Your account is not claimed yet. You can sign up with ORCID to claim your account.

Takashi Ikeda

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Bone marrow transplantation

Hematological oncology

Leukemia

Blood advances

Shizuoka Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shizuoka Cancer Center Mar 1o 2007

Japan

Chief :: Division of Hematology and Stem Cell Transplantation

Publications

Kazutaka Sunami, Shin-Ichi Fuchida, Kenshi Suzuki, Masaki Ri, Morio Matsumoto, Chihiro Shimazaki, Hideki Asaoku, Hirohiko Shibayama, Kenichi Ishizawa, Hiroyuki Takamatsu, Takashi Ikeda, Dai Maruyama, Kazunori Imada, Michihiro Uchiyama, Toru Kiguchi, Satoshi Iyama, Hirokazu Murakami, Reiko Onishi, Keisuke Tada, Shinsuke Iida
Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study. Hematological oncology (2022)
Hidenori Wada, Shinichi Kako, Sung-Won Kim, Yoshiaki Usui, Koji Kato, Takahiro Fukuda, Naoyuki Uchida, Hikaru Kobayashi, Toshio Wakayama, Emiko Sakaida, Shingo Yano, Kazunori Imada, Miho Nara, Takashi Ikeda, Shin-Ichi Fuchida, Jun Ishikawa, Hiroyuki Sugahara, Junya Kanda, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Eisei Kondo
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL. Leukemia 36 (5) (2022)
Yoshimitsu Shimomura, Masahiko Hara, Hisashi Yamamoto, Naoyuki Uchida, Toshiro Kawakita, Takashi Ashida, Satoru Takada, Takashi Ikeda, Satoshi Morishige, Yumiko Maruyama, Atsushi Wake, Tatsuo Ichinohe, Takahiro Fukuda, Minoko Takanashi, Yoshiko Atsuta, Takayuki Ishikawa
Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies. Bone marrow transplantation 56 (7) (2021)
Yu Akahoshi, Shun-Ichi Kimura, Yuma Tada, Toshihiro Matsukawa, Masaharu Tamaki, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Takuro Kuriyama, Ken-Ichi Matsuoka, Takashi Ikeda, Takafumi Kimura, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Murata, Seitaro Terakura, Hideaki Nakasone
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease. Blood advances (2021)
Nobuhiko Imahashi, Seitaro Terakura, Eisei Kondo, Koji Kato, Sung-Won Kim, Akihito Shinohara, Mizuki Watanabe, Takahiro Fukuda, Naoyuki Uchida, Hikaru Kobayashi, Jun Ishikawa, Keisuke Kataoka, Souichi Shiratori, Takashi Ikeda, Ken-Ichi Matsuoka, Shuro Yoshida, Tadakazu Kondo, Takafumi Kimura, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda
Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies. Bone marrow transplantation (2021)
Takashi Ikeda, Keita Mori, Koji Kawamura, Takehiko Mori, Shotaro Hagiwara, Yasunori Ueda, Kaoru Kahata, Naoyuki Uchida, Nobuhiro Tsukada, Satoshi Murakami, Masahide Yamamoto, Tsutomu Takahashi, Tatsuo Ichinohe, Makoto Onizuka, Yoshiko Atsuta, Yoshinobu Kanda, Shinichiro Okamoto, Kazutaka Sunami, Hiroyuki Takamatsu
Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Hematological oncology 37 (5) (2019)

Takashi Ikeda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takashi Ikeda